Pharmaceutical company ranking based on R&D for developing countries in 2018*

Pharma company ranking based on R&D for developing countries 2018 This statistic depicts a pharmaceutical company ranking based on R&D for developing countries in 2018, according to the Access to Medicine Index 2018. In that year, the leading company concerning research and development for these markets was GlaxoSmithKline with an indicator score of four points. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Show more
Loading statistic...
Expand statistic
Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc4
Merck KGaA3.69
Novartis AG3.55
Johnson & Johnson3.19
Sanofi2.83
Eisai Co. Ltd.2.8
Takeda Pharmaceutical Co.2.8
Daiichi Sankyo Co. Ltd.2.71
Bayer AG2.14
Novo Nordisk A/S2.09
AstraZeneca plc2.05
Astellas Pharma Inc.2.01
AbbVie Inc.1.98
Pfizer Inc.1.9
Roche Holding Ltd1.84
Merck & Co. Inc.1.78
Boehringer-Ingelheim GmbH1.73
Bristol-Myers Squibb Co.1.56
Gilead Sciences Inc.1.43
Eli Lilly & Co.0.88
Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc4
Merck KGaA3.69
Novartis AG3.55
Johnson & Johnson3.19
Sanofi2.83
Eisai Co. Ltd.2.8
Takeda Pharmaceutical Co.2.8
Daiichi Sankyo Co. Ltd.2.71
Bayer AG2.14
Novo Nordisk A/S2.09
AstraZeneca plc2.05
Astellas Pharma Inc.2.01
AbbVie Inc.1.98
Pfizer Inc.1.9
Roche Holding Ltd1.84
Merck & Co. Inc.1.78
Boehringer-Ingelheim GmbH1.73
Bristol-Myers Squibb Co.1.56
Gilead Sciences Inc.1.43
Eli Lilly & Co.0.88
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic depicts a pharmaceutical company ranking based on R&D for developing countries in 2018, according to the Access to Medicine Index 2018. In that year, the leading company concerning research and development for these markets was GlaxoSmithKline with an indicator score of four points. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Show more
Release date
November 2018
Region
Worldwide
Survey time period
2018
Supplementary notes
* The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
The Index uses a framework that evaluates company activities in seven areas of activity, or technical areas, considered to be key to enhancing access to medicine in developing countries, and across four important aspects of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.
Open this statistic in...

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom

Related Studies: Available to Download in PDF or PPTX Format

Monsanto-Bayer
Monsanto-Bayer

All Information
in one Presentation

Monsanto-Bayer

Everything On "Monsanto-Bayer" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Johnson & Johnson"

  • Key Figures
  • Johnson & Johnson's Impact on the Pharmaceutical Market
The most important statistics
  • Johnson & Johnson's Impact on the Medical Devices & Diagnostic Market
  • Johnson & Johnson's Impact on the Cosmetic Market
  • Forecasts
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News